DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

BMS-908662

Generic Name: BMS-908662

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₁₉ClN_₄O_₄

CAS Number: 870603-16-0

Unique Ingredient Identifier: DW2NWI3TFN

Overview

BMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.

Background

BMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma

Phase 1

Completed

Posted: 2010/11/22

Sponsor:Bristol-Myers Squibb

Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer

Phase 1

Completed

Posted: 2010/03/15

Sponsor:Bristol-Myers Squibb

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy